CAM
PBYI icon

ClariVest Asset Management’s Puma Biotechnology PBYI Stock Holding History

ClariVest Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,844
Closed -$635K – 749
2018
Q3 		$635K Sell
13,844
-309
-2% -$14.9K 0.01% 475
2018
Q2 		$838K Buy
14,153
+2,921
+26% +$169K 0.01% 465
2018
Q1 		$764K Buy
11,232
+100
+0.9% +$7.49K 0.01% 461
2017
Q4 		$1.1M Buy
+11,132
New +$1.25M 0.02% 415
2015
Q3 		– Sell
-5,971
Closed -$696K – 639
2015
Q2 		$696K Sell
5,971
-9
-0.2% -$1.63K 0.02% 314
2015
Q1 		$1.41M Sell
5,980
-94
-2% -$20.1K 0.04% 252
2014
Q4 		$1.15M Sell
6,074
-512
-8% -$114K 0.04% 217
2014
Q3 		$1.57M Buy
+6,586
New +$1.35M 0.06% 197

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return